Abstract 4424: Preclinical efficacy of a first-in-class anti-Integrin α/β ADC in hard-to-treat solid tumors
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Qinhong Ma, Daizong Li, Kewei Zhao, Mary Q. Xu, Mason Lu
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148648571
Cites:
Cited by:
Related to:
